抗敏龙头登康口腔:毛利率站上50%!

Core Viewpoint - The oral care industry is undergoing a transformation driven by increasing consumer awareness of oral health, with "professionalism" emerging as a new trend. Dengkang Oral (001328.SZ) is transitioning from a single product focus to an oral health ecosystem, leveraging its competitive edge in the sensitive toothpaste segment [4]. Group 1: Company Overview and Market Position - Dengkang Oral was established in 1999 and specializes in the research and sales of oral care products, with toothpaste being its core category. The company has a strong competitive advantage due to its unique sensitive technology, including dual sensitivity technology and bio-glass ceramic materials, which effectively address tooth sensitivity [5]. - Since 2021, Dengkang Oral has maintained over 60% market share in the sensitive toothpaste segment, reaching a new high of 64.7% in 2024 [5]. Group 2: Research and Development - The company's differentiation advantage stems from its continuous investment in research and development, with R&D expense ratios consistently between 3.0% and 3.5%, significantly higher than the industry average [8]. - As of mid-2025, Dengkang Oral has authorized over 260 domestic patents, including more than 30 invention patents, and has participated in drafting national and industry standards [10]. Group 3: Product Strategy and Financial Performance - Dengkang Oral is focusing on high-end product iterations and channel promotion, with products like the "Medical Research 7-Day Repair Toothpaste" priced at 39.9 yuan, double that of traditional products. The new "Recombinant Protein" series, priced at 49.9 yuan, achieved sales of 4.89 million yuan on Douyin in September, ranking first in its category [12]. - The sales proportion of mid-to-high-end toothpaste products reached approximately 40% in the first half of 2025, contributing to improved profitability, with a gross margin of 49.4% in 2024, up 5.3 percentage points year-on-year, and further increasing to 50.5% in the first three quarters of 2025 [12]. Group 4: Strategic Expansion Plans - In December 2025, Dengkang Oral announced its "8462 Leap Action - 14th Five-Year Plan," aiming to expand into four key areas: oral care, smart oral, oral medical, and innovative businesses [20]. - The company plans to invest approximately 113 million yuan by 2026 to focus on the oral health ecosystem, with a goal of doubling revenue and profit during the 14th Five-Year period [22][23]. - As of the third quarter of 2025, Dengkang Oral had cash and cash equivalents totaling nearly 1.5 billion yuan, providing a solid financial foundation for its business upgrades [25].